Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus. - Wikidata - awgldk - TriplyDB

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q37274957

about

Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies.Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1.Metformin and lung cancer risk in patients with type 2 diabetes mellitus.Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese versus lean mice.Risk of gastric cancer development after eradication of Helicobacter pylori.Differential Expression of IL-10 Gene and Protein in Target Tissues of Rattus Norvegicus Strain Wistar Model Type 2 Diabetes Mellitus (T2DM)

P2860

Q33648824-0D189844-03CD-4D80-A981-BBF8C5F56C79 Q36348876-ED272ACB-82B2-498C-9ACE-2DF857E9FC70 Q36370966-9961FC91-3CAD-471A-87BC-C0F0BB762355 Q37745840-F4AA3526-1F62-4C45-8E9F-7D84D12AA99F Q38735613-D5B527CA-FFA5-42BA-B6E8-FBA2F8F6B02E Q41092838-195C6A6F-F991-4629-A139-A99657C01694 Q49194546-F236FC7D-0DC0-426E-9D71-426720763E73 Q54209299-4596D8FE-384F-4D58-98BC-CAA6D4FAA9FB Q57100668-EBE19BC8-1059-41F6-8B85-68311DA4755A

P2860

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q37274957

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.

@en

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.

@nl

type

label

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.

@en

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.

@nl

prefLabel

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.

@en

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.

@nl

P1433

Q37274957-BB21BA54-C940-4457-917F-A3E02414B69A

P1476

Q37274957-4E79A334-DFBF-42B6-AB8E-74EEDFB79721

P2093

Q37274957-C262FA58-F771-47D6-A968-1EFF0BCBF196

P2860

Q37274957-00A7CBCA-C230-484B-94F8-67119C805D38

Q37274957-0D4248B7-7659-43A7-B774-4DBFC13C65B8

Q37274957-0DA6D911-D4B7-47DC-A613-7CA2F5D94D59

Q37274957-12A1E23B-B52E-4382-9175-9DFF6BBE15E6

Q37274957-1B43F22E-A68C-4C4C-B515-A51826055FE8

Q37274957-1BFA42BA-905E-4743-A6C6-1B3FB87F02DB

Q37274957-1D2B0C8D-7EDA-4483-B0D4-C7DDF63EEA7D

Q37274957-1D712A80-4DC7-4B48-AF86-9C9F9F35E7C3

Q37274957-219172C3-6BE9-4A25-89DF-932BF62CC695

Q37274957-22A453A6-E5D6-49A2-A610-2FBD025CD420

P304

Q37274957-CDFCDDB8-6409-42FB-86BE-90AA01363B34

P31

Q37274957-B9957BD1-5BAF-449D-9CF3-2F85F6A285B5

P356

Q37274957-AA7136FA-D20E-40DF-B625-D3F4D8D80DC3

P433

Q37274957-4379D422-420A-4167-BAA5-38E1715AD2B3

P478

Q37274957-ABAFEFF5-E3D8-4FDB-8723-DEE91A52758D

P577

Q37274957-C1ED5544-F4B8-4EB6-9C7A-8C845DF56B5F

P698

Q37274957-D3F732C7-5CC9-4434-98C5-D852275D7FFF

P921

Q37274957-011C2EC2-067C-48BA-9AF2-1D76DED705F1

Q37274957-492E9F29-40D4-44BB-AD6F-B87B7A0A39AE

P932

Q37274957-D434B798-7CAA-42BC-955A-25D5381BBE62

P356

P1433

P1476

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.

@en

P2093

Chin-Hsiao Tseng

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes and gastric cancer: the potential links

New mechanisms of metformin action: Focusing on mitochondria and the gut

The stomach in health and disease

Global cancer statistics, 2012

Metformin and reduced risk of cancer in diabetic patients

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.

Diabetes, insulin use and Helicobacter pylori eradication: a retrospective cohort study.

Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.

Use of fibrates and cancer risk: a systematic review and meta-analysis of 17 long-term randomized placebo-controlled trials

Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current

P304

1636-1649

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/AGING.101019

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27587088

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5032687

http://www.w3.org/2001/XMLSchema#string